Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10
Authors
Keywords
-
Journal
CLINICAL & EXPERIMENTAL METASTASIS
Volume 28, Issue 8, Pages 793-802
Publisher
Springer Nature
Online
2011-07-26
DOI
10.1007/s10585-011-9410-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
- (2010) Keith Brew et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Matrix Metalloproteinase-9 Functions as a Tumor Suppressor in Colitis-Associated Cancer
- (2010) P. Garg et al. CANCER RESEARCH
- Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α
- (2010) Florian Schelter et al. CLINICAL & EXPERIMENTAL METASTASIS
- Identification of a Survival-independent Metastasis-enhancing Role of Hypoxia-inducible Factor-1α with a Hypoxia-tolerant Tumor Cell Line
- (2010) Florian Schelter et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Disintegrin and Metalloproteinase-10 (ADAM-10) Mediates DN30 Antibody-induced Shedding of the Met Surface Receptor
- (2010) Florian Schelter et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Avoiding spam in the proteolytic internet: Future strategies for anti-metastatic MMP inhibition
- (2009) Achim Krüger et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Ectodomain shedding of E-cadherin and c-Met is induced by Helicobacter pylori infection
- (2009) Wiebke Schirrmeister et al. EXPERIMENTAL CELL RESEARCH
- Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by host-derived urokinase-type plasminogen activator
- (2009) Florian Schrötzlmair et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival
- (2009) Charlotte Aaberg-Jessen et al. JOURNAL OF NEURO-ONCOLOGY
- High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents
- (2009) Evangelos Terpos et al. LEUKEMIA RESEARCH
- mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: Potential role of TIMP1 as an adverse prognostic factor
- (2009) Carlos Alberto Scrideli et al. LEUKEMIA RESEARCH
- Down-Regulation of the Met Receptor Tyrosine Kinase by Presenilin-dependent Regulated Intramembrane Proteolysis
- (2009) Bénédicte Foveau et al. MOLECULAR BIOLOGY OF THE CELL
- Functional genetic mouse models: promising tools for investigation of the proteolytic internet
- (2008) Achim Krüger BIOLOGICAL CHEMISTRY
- Matrix Metalloproteinase-8 Functions as a Metastasis Suppressor through Modulation of Tumor Cell Adhesion and Invasion
- (2008) A. Gutierrez-Fernandez et al. CANCER RESEARCH
- ADAM10 as a Target for Anti-Cancer Therapy
- (2008) Marcia Moss et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Distinct Functionality of Tumor Cell-Derived Gelatinases during Formation of Liver Metastases
- (2008) M. Gerg et al. MOLECULAR CANCER RESEARCH
- Drug development of MET inhibitors: targeting oncogene addiction and expedience
- (2008) Paolo M. Comoglio et al. NATURE REVIEWS DRUG DISCOVERY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started